[HTML][HTML] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults
X Xu, Y Zheng, X Zhang, Y He, C Li - Oncotarget, 2017 - ncbi.nlm.nih.gov
Objective Atopic dermatitis is a chronic, relapsing inflammatory skin disease characterized
by intense pruritus, excoriations and limited therapies. Dupilumab, a monoclonal antibody …
by intense pruritus, excoriations and limited therapies. Dupilumab, a monoclonal antibody …
Atopic dermatitis in adults
L Zeppa, V Bellini, P Lisi - DERM, 2011 - liebertpub.com
Atopic dermatitis (AD) is a chronically relapsing eczematous disease, more common in
infants and children than in adults and very rare after midlife. The diagnosis of AD is not …
infants and children than in adults and very rare after midlife. The diagnosis of AD is not …
[引用][C] Dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: a 12-week, Randomized, Double-Blind, Placebo-Controlled Study
TRM Bieber, D Thaci, N Graham, G Pirozzi… - Journal of Allergy and …, 2014 - jacionline.org
Methods This European trial randomized adults with moderate-to-severe atopic dermatitis
poorly controlled by topical agents to 12 weekly subcutaneous doses of placebo (n= 54) or …
poorly controlled by topical agents to 12 weekly subcutaneous doses of placebo (n= 54) or …
Atopic dermatitis: new developments
A Kusari, AM Han, D Schairer… - Dermatologic …, 2019 - derm.theclinics.com
The 2010s have been called the decade of eczema, and for good reason. Exciting
developments in basic science are reshaping our fundamental understanding of atopic …
developments in basic science are reshaping our fundamental understanding of atopic …
Dupilumab: a review of its use in the treatment of atopic dermatitis
MJ Gooderham, HC Hong, P Eshtiaghi… - Journal of the American …, 2018 - Elsevier
Atopic dermatitis (AD) is a chronic, pruritic immune-mediated inflammatory dermatosis
characterized by a T helper 2 (Th2) immune response phenotype and may be associated …
characterized by a T helper 2 (Th2) immune response phenotype and may be associated …
Treatment of atopic dermatitis
TY Han, CH Na, JH Lee, HO Kim… - Korean Journal of …, 2018 - cuk.elsevierpure.com
Atopic dermatitis (AD) is a common, chronic, relapsing, inflammatory skin disease that
affects both children and adults. AD is the cause of considerable morbidity including severe …
affects both children and adults. AD is the cause of considerable morbidity including severe …
Atopic Dermatitis—Beyond the Skin
Atopic dermatitis is a chronic inflammatory disease that can arise during the first months of
life or at maturity and have a significant negative impact on the quality of life. The main …
life or at maturity and have a significant negative impact on the quality of life. The main …
Adulthood atopic dermatitis: epidemiology, clinical symptoms, provoking and prognostic factors
G Pónyai, E Temesvári, S Kárpáti - Orvosi Hetilap, 2007 - akjournals.com
The prevalence of atopic diseases, including allergic rhinitis, asthma bronchiale and atopic
dermatitis is increasing both in children and adults at different parts of the world. Atopic …
dermatitis is increasing both in children and adults at different parts of the world. Atopic …
Efficacy and safety of dupilumab in atopic dermatitis in elderly patients: a retrospective study
M Napolitano, G Fabbrocini, M Scalvenzi… - Clinical and …, 2020 - academic.oup.com
Atopic dermatitis (AD) is a common inflammatory skin disease with high prevalence in both
children (15–30%) and adults (2–10%), but limited data are available for older people …
children (15–30%) and adults (2–10%), but limited data are available for older people …
[PDF][PDF] Dupilumab reduces inflammation and restores the skin barrier in patients with atopic dermatitis.
MH Rohner, K Thormann, S Cazzaniga, S Yousefi… - Allergy, 2021 - boris.unibe.ch
The pathogenesis of atopic dermatitis (AD), a common chronic inflammatory skin disease, is
based on a genetic predisposition that determines both skin barrier function and type 2 …
based on a genetic predisposition that determines both skin barrier function and type 2 …